Candy Swift

Surgery, radiotherapy, and chemotherapy have always been the main treatment methods for malignant tumors. In recent years, with a deeper exploration of gene technology, the development of molecular...

On January 26, 2022, the U.S. Food and Drug Administration (FDA) approved the marketing of Kimmtrak (Tebentafusp-tebn), an innovative therapy from a British biotechnology company, for the treatment of...

Oncolytic viruses (OVs) are a new force in immunotherapy, a therapeutic strategy that has attracted a lot of attention and made great progress in recent decades. As researchers explore further on...

Gene therapy is a hot topic in clinical research today — and for good reason! These technologies have the potential to treat — and in some cases even cure — a wide range of conditions, including rare...

Recently, studies have proved that CRISPR-based gene silencing technology can alleviate chronic pain in mice. Although the therapy is still a long way from human use, scientists predict that it is a...

Solid tumors are currently the main cause of cancer incidence and mortality in the world. Although immunotherapies such as PD-1/L1 antibodies, chimeric antigen receptor T cell (CAR-T), and oncolytic...

Complement is an important part of the body's immune regulation network, not only participates in anti-infection immunity, but also has multiple functions such as regulating inflammatory response...

Immuno-oncology (IO), emerging as a novel approach to taking advantage of the body's immune system to fight cancer, has been a game changer in cancer treatment research. With abundant drug development...

As one of the most threatening diseases, HIV has been studied for dozens of years. Recently, convertibleCAR-T Cells have been a hot issue in HIV treatment and Creative Biolabs has invited Dr. Eytan...

For several years, chimeric antigen receptor (CAR) T cell therapy has been a hot issue in tumor treatment, and since it faces obstacles in solid tumors, CAR macrophage therapy has emerged as a new...

According to the latest market report about liposome and nanoparticle drug delivery, the market size and market share continue to expand in 2023 and will be expected to touch USD 8977.8 million by...

Environmental factors, such as ultraviolet light, can cause DNA damage in organisms. In humans and animals, this DNA damage may cause cancer. Fortunately, cells themselves have several different...

Recently, studies have proved that CRISPR-based gene silencing technology can alleviate chronic pain in mice. Although the therapy is still a long way from human use, scientists predict that it is a...

The 2020 Nobel Prize in Chemistry has made CRISPR an instant hit. So how did CRISPR get preferred by the committee to receive this fabulous prize? This article will introduce the details of CRISPR...

Gene therapy is emerging as a therapeutic option for a rising range of diseases three decades after its first introduction. Researchers have created therapies for a variety of blood diseases, as well...